Moyamoya syndrome as a risk factor for stroke in Saudi children. Novel and usual associations

Saudi Medical Journal

Volumn 27, Issue SUPPL., 2006, Pages

  Salih, Mustafa A M ^a   Murshid, Waleed R ^b   Al Salman, Mussaad M ^a   Abdel Gader, Abdel Galil M ^a   Al Jarallah, Ahmed A ^a   Alorainy, Ibrahim A ^a   Hassan, Hamdy H ^a   Kentab, Amal Y ^a   Van Maldergem, Lionel ^c   Othman, Saleh A ^a   El Desouki, Mahmoud I ^a   Elgamal, Essam A ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c INSTITUTE OF PATHOLOGY AND GENETICS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARBAMAZEPINE; HYDROXYUREA; PARACETAMOL;

ADAMS OLIVER SYNDROME; ARTICLE; BETA THALASSEMIA; BRAIN SCINTISCANNING; CEREBROVASCULAR ACCIDENT; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONVENTIONAL ANGIOGRAPHY; CONVULSION; DISEASE ASSOCIATION; FEMALE; GENETIC COUNSELING; HEADACHE; HUMAN; INFANT; LOW DRUG DOSE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MOYAMOYA DISEASE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PROSPECTIVE STUDY; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RETROSPECTIVE STUDY; REVASCULARIZATION; SAUDI ARABIA; SICKLE CELL ANEMIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THROMBOPHILIA;

CEREBROVASCULAR ACCIDENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MOYAMOYA DISEASE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SAUDI ARABIA;

EID: 33645214045     PISSN: 03795284     EISSN: 03795284     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Suzuki J. Moyamoya disease. Berlin: Springer-Verlag, 1983.
2. Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969; 20: 288-299.
3. Suzuki J, Kodama N. Moyamoya disease - A review. Stroke 1983; 14: 104-109.
4. Kim SK, Wang KC, Kim DG, Paek SH, Chung HT, Han MH et al. Clinical feature and outcome of pediatric cerebrovascular disease: a neurosurgical series. Childs Nerv Syst 2000; 16: 421-428.
5. Roach ES, Riela AR, editors. Pediatrics cerebrovascular disorders. Armonk, (NY): Futura Publishing Company, Inc; 1995.
6. Garg BP, Bruno A, Biller J. Moyamoya disease and cerebral ischemia. In: Batjer HH, editor. Cerebrovascular disease. Philadelphia (PA): Lippincott-Raven Publisher; 1997. p. 489-499.
7. Ganesan V, Prengler M, McShane MA, Wade A, Kirleman FJ. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003; 53: 167-173.
8. Sabde S, Tullu MS, Lahiri KR, Vaswani RK. Moyamoya syndrome in a child with Down syndrome. Arch Med Res 2005; 36: 421-424.
9. Han DH, Kwon OK, Byun BJ, Choi CW, Choi JU, Choi SG et al. A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular Disease. Acta Neurochin (Wien) 2000; 142: 1263-1273.
10. Scott RM. Moyamoya syndrome: a surgically treatable cause of stroke in the pediatric patient. Clin Neurology 2000; 47: 378-384.
11. Scott RM. Surgery for moyamoya syndrome? Yes. Arch Neurol 2001; 58: 128-129.
12. Fung LW, Thompson D, Ganesan V. Revascularization surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst 2005; 21: 358-364.
13. Salih MA, Abdel-Gader AM, Al-Jarallah AA, Kentab AY, Alorainy IA, Hassan HH et al. Stroke in Saudi children. Epidemiology, clinical features and risk factors. Saudi Med J 2006; Vol. 27 Supplement 1: S12-S20.
14. Salih MA, Abdel-Gader AM, Al-Jarallah AA, Kentab AY, Alorainy IA, Hassan HH et al. Hematologic risk factors for stroke in Saudi children. Saudi Med J 2006; Vol. 27 Supplement 1: S21-S34.
15. Salih MA, Andeejani AM, Gader AM, Kolawole T, Palkar V. Moyamoya syndrome associated with protein C deficiency. Med Sci Res 1995; 23: 573-575.
16. Andeejani AM, Salih MA, Kolawole T, Gader AM, Malabarey TO, Al-Damegh S et al. Moyamoya syndrome with unusual angiographic findings and protein C deficiency: review of the literature. J Neurol Sci 1998; 159: 11-16.
17. Khan-Ghori SN, Murshid WR, Samarkandi AH, Al-Salman M, Salih MA. Use of propofol and seroflurane in moyamoya disease. Middle East J Anesthesiol 1999; 15: 73-81.
18. Ganesan V, Prengler M, McShane MA, Wade A, Kirleman FJ. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003; 53: 167-173.
19. De Veber G. Vascular occlusion in moyamoya: A multitude of mechanisms? Stroke 2001; 32: 1791-1792.
20. Nowak-Gottl U, Gunther G, Kurnik K, Strater R, Kirkhan F. Arterial ischemic stroke in neonates, infants, and children: an overview of underlying conditions, imaging methods and treatment modalities. Semin Thromb Hemost 2003; 29: 405-414.
21. Charwanji A, Laothamatas J, Torchorus K, Sirivimonmas S. Moyamoya disease and protein S deficiency: a case report. Pediatr Neurol 1997; 17: 171-173.
22. Tsuda H, Hattori S, Tanabe S, Nishioka S, Matsushima T, Ikezaki K et al. Thrombophilia found in patients with moyamoya disease. Clin Neurol Neurosurg 1997; 99 (Suppl 2): S229-S233.
23. Akgun D, Yilmaz S, Senbil N, Aslan B, Gurer YY. Moyamoya syndrome with protein S deficiency. Eur J Paediatr Neurol 2000; 4: 185-188.
24. Bonduel M, Hepner M, Sciuccati G, Torres AF, Tenembaun S. Prothrombotic disorders in children with moyamoya syndrome. Stroke 2001; 32: 1786-1790.
25. Fujurara S, Miyazono M, Tsuda H, Fukui M. Intraventricular hemorrhage and cerebral ischemic attacks in the presence of lupus anticoagulant mimicking moyamoya disease. J Neurosurg Sci 1993; 37: 161-164.
26. McCurdy D, Sanematsu L, Sandburg C, Nugent D. Anticardiolipin antibodies (ACLA) in children with cerebrovascular accidents. Thromb Haemost 1993; 69: 1225.
27. Stockman JA, Nigro MA, Mishkini MM, Oski FA. Occlusion of large cerebral vessels in sickle-cell anemia. N Engl J Med 1972; 287: 846-849.
28. Dobson SR, Holden KR, Nietert PJ, Cure JK, Laver JH, Disco D et al. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 2002; 99: 3144-3150.
29. Pegelow CH, Wang W, Granger S, Hsu LL, Vichinsky E, Moser FG et al. Silent infants in children with sickle cell anemia and abnormal cerebral aftery velocity. Arch Neurol 2001; 58: 2017-2021.
30. Adams FH, Oliver CP. Hereditary deformities in man due to arrested development. J Hered 1945; 36: 3-7.
31. Koiffmann CP, Wajntal A, Huyke BJ, Castro RM. Congenital scalp skull defects with distal limb anomalies (Adams-Oliver Syndrome-MC Kusick 10030): further suggestion of autosomal recessive inheritance. Am J Med Genet 1988; 29: 263-268.
32. Savarinayan R, Thompson EM, Abbott KJ, Moore MH. Cerebral cortical dysplasia and digital constriction rings in Adams-Oliver syndrome. Am J Med Genet 1999; 86: 15-19.
33. Caksen H, Kutoglu S. A case of Adams-Oliver Syndrome associated with acrania, microcephaly, hemiplegia, epilepsy, and mental retardation. Acta Neurol Belg 2000; 100: 252-255.
34. Piazza AJ, Blackston D, Sola A. A case of Adams-Oliver syndrome with associated brain and pulmonary involvement: further evidence of vascular pathology? Am J Med Genet A 2004; 130: 172-175.
35. Scriband N, Temtamy SA. Syndrome of aplasia cutis congenital with terminal transverse defects of limbs. J Pediatr 1975; 87: 79-82.
36. Tekin M, Bodurtha J, Ciftci E, Arjan S. Further family with possible autosomal recessive inheritance of Adams-Oliver syndrome. (Letter) Am J Med Genet 1999; 86: 90-91.
37. Becker R, Kunze J, Horn D, Gasiorek-Wiens A, Entezami M, Rossi R et al. Autosomal recessive type of Adams-Oliver syndrome: prenatal diagnosis. Ultrasound Obstet Gynecol 2002; 20: 506-510.
38. Toriello HV, Graff RG, Florentino MF, Lacina S, Moore WD. Scalp and limb defects with cutis mormorata telangiectasia congenital: Adams-Oliver syndrome? Am J Med Genet 1988; 29: 269-276.
39. Swartz EW, Sanatani S, Sandor GGS, Schreiber RA. Vascular abnormalities in Adams-Oliver syndrome: cause or effect? Am J Med Genet 1999; 82: 49-52.
40. Maniscalco M, Zedda A, Faraone S, Laurentiis G, Verde R, Molese V et al. Association of Adams-Oliver syndrome with pulmonary arterio-venous malformation in the same family: A further support to the vascular hypothesis. Am J Med Genet A 2005; 136: 269-274.
41. Hartfield DS, Lowry NJ, Keene DL, Yager JY. Iron deficiency: A cause of stroke in infants and children. Pediatr Neurol 1997; 16: 50-53.
42. Gazit E, Goodman RM, Katznelson MB, Rotem Y. The wrinkly skin syndrome: a new heritable disorders of connective tissue. Clin Genet 1973; 4: 186-192.
43. Karrar ZA, Elidrissy AT, Al Arabi K, Adam KA. The wrinkly skin syndrome: a report of two siblings from Saudi Arabia. Clin Genet 1983; 23: 308-310.
44. Casamassima AC, Wesson SK, Conlon CJ, Weiss FH. Wrinkly skin syndrome: phenotype and additional manifestations. Am J Med Genet 1987; 27: 885-893.
45. Kreuz FR, Wittner BH. Del(2q). Cause of the wrinkly skin syndrome? Clin Genet 1993; 43: 132-138.
46. Boente MC, Winik BC, Asial RA. Wrinkly skin syndrome: ultrastructural alterations of the elastic fibres. Pediatr Dermatol 1999; 16: 113-117.
47. Yamamoto M, Aoyagi M, Tajima S, Wachi H, Fukai N, Matsushima Y et al. Increase in elastin gene empression and protein synthesis in arterial smooth muscle cells derived from patients with moyamoya disease. Stroke 1997; 28: 1733-1738.
48. Kashiwagi S, Yamashita T, Katoh S, Kitahara T, Nakashima K, Yasuhara S et al. Regression of moyamoya vessels and hemodynamic changes after successful revascularization in childhood moyamoya disease. Acta Neurol Scand Suppl 1996; 166; 93-95.
49. Nakashima H, Meguro T, Kawada S, Hirotsune N, Ohimoto T. Long-term results of surgically treated moyamoya disease. Clin Neurol Neurosurg 1997; 99 (Suppl 2): S156-S161.
50. Smith ER, Butler WE, Ogioloy CS. Surgical approaches to vascular anomalies of the child's brain. Curr Opin Neurol 2002; 15: 165-171.
51. Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff M. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 2004; 100 (2 Suppl): 142-149.
52. Fryer RH, Anderson RC, Chiriboga CA, Feldstein NA. Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure. Pediatr Neurol 2003; 29: 124-130.
53. Touho H, Karasawa J, Ohnishi H. Preoperative and post operative evaluation of cerebral perfusion and vasodilatory capacity with 99m-Tc-HMPAO SPECT and acetazolamide in childhood moyamoya disease. Stroke 1996; 27: 282-289.
54. Salih MA, Abdel-Gader AM, Al-Jarallah AA. Study project on stroke in Saudi children. Conclusions, recommendations and acknowledgments. Saudi Med J 2006; Vol. 27 Supplement 1: S108-S110.